Skip to content

Psychedelic-assisted therapy: all studies

Page 162 of 294: studies 1,611 to 1,620 of 2,936, newest first. Back to the psychedelic-assisted therapy overview

Research

Psilocybin-assisted treatment of depression

Medical Science July 30, 2025 Barbara Anna Zapalska, Antonina Teresa Witkowska, Anna Cukrowska et al.

Depression, a common mental disorder, affects people at different stages of life.Classic antidepressant treatment is generally effective, however, it is prolonged.Nonetheless, numerous patients who undergo various classic antidepressant therapies still suffer from depression.Therefore, the search for novel medications is essential.In this review, we explore the therapeutic potential of...

“Skin contains land and birds”: Understanding inner healing intelligence through critical vitalism and Indigenous thought

Journal of Psychedelic Studies July 28, 2025 Keith Williams, Andrée-anne Bédard, Laura Pustarfi 1 citation

Inner healing intelligence (IHI) is a foundational orienting concept in the psychedelic-assisted therapy (PAT) field that refers to the innate tendency of living beings to move towards healing. In this paper, we introduce an expanded articulation of IHI, drawing largely on vitalism and Indigenous philosophy from the Americas. We conceptualize IHI as the innate capacity of an individual to move...

Ganzflicker as a Psychedelic Tool: Alpha-Linked Brightening of Visual Hallucinations

July 27, 2025 Pete Carr preprint

Psychedelic-assisted psychotherapy emphasizes the transformative power of mystical-type peak experiences. Stroboscopic ganzfeld (ganzflicker) stimulation offers a non-pharmacological analogue to psychedelic drugs. This exploratory self-experimentation study investigated whether anxiety-neutralizing techniques (eye movements, square breathing) enhance the brightness of visual hallucinations...

DOI: 10.31234/osf.io/r6m75_v7 (opens in new tab) Visual hallucination Alpha finance Cognitive psychology Developmental psychology

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction July 24, 2025 Amandine Luquiens, Dahbia Belahda, Carine Graux et al. 22 citations

Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted psychotherapy for patients with comorbid...

DOI: 10.1111/add.70152 (opens in new tab) Alcohol use disorder Dual disorders Feasibility Psychedelics +14

Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older Patients

American Journal of Geriatric Psychiatry July 23, 2025 Charlotte M. Gillespie, Jesse M. Bering 3 citations

Psilocybin's efficacy as a treatment for treatment-resistant depression (TRD) has led to a wave of new legislation permitting its usage in medical settings. Older adults are affected disproportionately by TRD and may be especially good candidates for this promising treatment. However, due to the drug's past (and present) illicit status and exposure to historic antidrug messaging, older...

The effect of psychedelics on associative learning: a systematic review

bioRxiv July 22, 2025 Alice Caulfield, Lorraine Li, Famia Askari et al. preprint

Introduction: Psychedelics are emerging as potential treatments for neuropsychiatric conditions, with evidence suggesting a single administration can lead to enduring behavioural changes. While the underlying putative mechanism(s) remain unclear, there is evidence supporting altered learning as a key candidate. Aim: This systematic review examined studies assessing the effects of psychedelics...

DOI: 10.1101/2025.07.21.665870 (opens in new tab) Neuroplasticity Cognitive enhancement Brain function enhancement Learning improvement +8

Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness.

The British Journal of Psychiatry July 21, 2025 Amy Lehrner, Thomas B Hildebrandt, Rachel Yehuda

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

DOI: 10.1192/bjp.2025.51 (opens in new tab) Methodology Placebo Psychotherapy Randomised clinical trial +1

Psychedelic Herbal Medicines: Exploring the Renaissance of a Therapeutic Frontier

International Journal of Ayurvedic Medicine July 21, 2025 Gaurav Mude, Shantilal Singune, Raghvendra Dubey

A revolutionary change in contemporary therapeutic paradigms may be seen in the renewed interest in psychedelic plant remedies. Psychedelic plants like psilocybe mushrooms, ayahuasca, iboga, and salvia divinorum, which have long been valued for their spiritual and therapeutic qualities in a variety of cultures, are now the subject of intense scientific research. According to recent clinical...

DOI: 10.47552/ijam.v16is2.6197 (opens in new tab) The renaissance Frontier Traditional medicine Pharmacology +1

Quantitative and qualitative influences of spiritual connection and natural imagery on perception of art in clinical psychedelic dosing settings.

Scientific Reports July 21, 2025 Suhjung Janet Lee, Claudia Epland, Noah Kaitz et al. 1 citation

Psychedelic clinical study environments are frequently visually manipulated, such as art; however, there has been little study of how the art selected for display impacts individual responses to the overall setting. To examine how individual self-identities shape perceptions of art used in a clinical psychedelic dosing environment, this study used a community-engaged mixed-methods approach....

Females in Psychedelic Research: A Perspective for Advancing Research and Practice.

ACS Pharmacology & Translational Science July 11, 2025 Zahira Ziva Cohen, Grace Blest‐hopley 9 citations

The influence of ovarian hormone fluctuations on neurochemistry, cognition, and psychological responses remains insufficiently examined in current psychedelic research and clinical protocols. Traditional practices and case studies underscore the importance of accounting for these factors in investigations of psychedelic effects. This opinion paper explores the critical intersections between...